The Effect of Sperm DNA Fragmentation on Fertilization Outcomes for Women With Polycystic Ovary Syndrome

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Jun 17

PMID 35712248

Authors

Huan Wang

Hui Li

Jing Zhu

Jianmin Xu

Yuqing Jiang

Wenhui Chen

Yingpu Sun

Qingling Yang

Affiliations

Soon will be listed here.

Abstract

Background: Polycystic ovary syndrome (PCOS) is a prevalent endocrine disease in reproductive women associated with poor pregnancy outcomes. In modern society, people pay more attention to the female factor, but it is uncertain whether sperm quality is another factor affecting pregnancy outcomes of patients with PCOS.

Method: The effect of sperm DNA fragmentation (SDF) on oocyte fertilization, embryonic development, and pregnancy outcomes for patients with PCOS who underwent fertilization (IVF) treatment was studied. A total of 141 PCOS patients and 332 control patients undergoing IVF treatment were recruited from January 2017 to December 2019. All female patients were designated into two groups according to the Rotterdam criteria. Each group was divided into two sets, DNA fragmentation index (DFI) ≤15% and DFI > 15%, on the basis of sperm DFI.

Result: There were no differences in basic clinical characteristics between couples with a sperm DFI ≤ 15% or DFI > 15%. For control patients, no differences were observed in IVF outcomes. However, for PCOS patients, although there were no differences in the fertilization (60.4% vs. 59.9%, p = 0.831), high-quality embryo (68.5% vs. 67.9% p = 0.832), clinical pregnancy (78.4% vs. 66.7%, p = 0.148), and abortion (12.5% vs. 11.5%, p = 1.000) rates, a significantly lower high-quality blastocyst formation rate (26.3% vs. 16.3%, p = 0.023) was observed for couples with a sperm DFI > 15% compared with a sperm DFI ≤ 15%.

Conclusion: For PCOS patients undergoing IVF, oocytes fertilized using sperm with higher DFI led to a lower high-quality blastocyst formation rate but had no influence on fertilization, high-quality embryo, clinical pregnancy, and miscarriage rates.

Citing Articles

Optimized sperm selection: a highly efficient device for the isolation of progressive motile sperm with low DNA fragmentation index.

Mateizel I, Racca A, Aligianni E, Distasi E, Baert Y, Segers I J Assist Reprod Genet. 2024; 41(8):2201-2209.

PMID: 38890266 PMC: 11339219. DOI: 10.1007/s10815-024-03168-9.

The impact of female BMI on sperm DNA damage repair ability of oocytes and early embryonic development potential in intracytoplasmic sperm injection cycles.

Jiang Y, Shen Z, Xu J, Zhu J, Wang H, Chen W Front Endocrinol (Lausanne). 2023; 14:1168010.

PMID: 37780615 PMC: 10534975. DOI: 10.3389/fendo.2023.1168010.

Correlations between elevated basal sperm DNA fragmentation and the clinical outcomes in women undergoing IUI.

Zhu C, Zhang S, Chen F, She H, Ju Y, Wen X Front Endocrinol (Lausanne). 2022; 13:987812.

PMID: 36120437 PMC: 9478029. DOI: 10.3389/fendo.2022.987812.

References

Sigman M . Significance of sperm DNA fragmentation and paternal age. Fertil Steril. 2020; 114(2):262. DOI: 10.1016/j.fertnstert.2020.05.011. View

Aversa A, La Vignera S, Rago R, Gambineri A, Nappi R, Calogero A . Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions. Front Endocrinol (Lausanne). 2020; 11:516. PMC: 7431619. DOI: 10.3389/fendo.2020.00516. View

Wang F, Dai W, Yang X, Guo Y, Sun Y . Analyses of optimal body mass index for infertile patients with either polycystic or non-polycystic ovary syndrome during assisted reproductive treatment in China. Sci Rep. 2016; 6:34538. PMC: 5043278. DOI: 10.1038/srep34538. View

Yang H, Li G, Jin H, Guo Y, Sun Y . The effect of sperm DNA fragmentation index on assisted reproductive technology outcomes and its relationship with semen parameters and lifestyle. Transl Androl Urol. 2019; 8(4):356-365. PMC: 6732090. DOI: 10.21037/tau.2019.06.22. View

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale H, Futterweit W . Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006; 91(11):4237-45. DOI: 10.1210/jc.2006-0178. View

Heijnen E, Eijkemans M, Hughes E, Laven J, Macklon N, Fauser B . A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update. 2005; 12(1):13-21. DOI: 10.1093/humupd/dmi036. View

Cissen M, van Wely M, Scholten I, Mansell S, de Bruin J, Mol B . Measuring Sperm DNA Fragmentation and Clinical Outcomes of Medically Assisted Reproduction: A Systematic Review and Meta-Analysis. PLoS One. 2016; 11(11):e0165125. PMC: 5104467. DOI: 10.1371/journal.pone.0165125. View

Hart R, Hickey M, Franks S . Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004; 18(5):671-83. DOI: 10.1016/j.bpobgyn.2004.05.001. View

Grundy S . Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol. 1998; 81(4A):18B-25B. DOI: 10.1016/s0002-9149(98)00033-2. View

10.

Weghofer A, Munne S, Chen S, Barad D, Gleicher N . Lack of association between polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril. 2007; 88(4):900-5. DOI: 10.1016/j.fertnstert.2006.12.018. View

11.

Chen H, Liao S, Cheung M, Chow P, Cheung A, O W . Effects of sperm DNA damage on the levels of RAD51 and p53 proteins in zygotes and 2-cell embryos sired by golden hamsters without the major accessory sex glands. Free Radic Biol Med. 2012; 53(4):885-92. DOI: 10.1016/j.freeradbiomed.2012.06.007. View

12.

Setti A, Braga D, Provenza R, Iaconelli Jr A, Borges Jr E . Oocyte ability to repair sperm DNA fragmentation: the impact of maternal age on intracytoplasmic sperm injection outcomes. Fertil Steril. 2021; 116(1):123-129. DOI: 10.1016/j.fertnstert.2020.10.045. View

13.

Marchetti F, Bishop J, Gingerich J, Wyrobek A . Meiotic interstrand DNA damage escapes paternal repair and causes chromosomal aberrations in the zygote by maternal misrepair. Sci Rep. 2015; 5:7689. PMC: 4286742. DOI: 10.1038/srep07689. View

14.

Nestler J, Jakubowicz D . Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab. 1997; 82(12):4075-9. DOI: 10.1210/jcem.82.12.4431. View

15.

Fatehi A, M M Bevers , Schoevers E, Roelen B, Colenbrander B, Gadella B . DNA damage in bovine sperm does not block fertilization and early embryonic development but induces apoptosis after the first cleavages. J Androl. 2005; 27(2):176-88. DOI: 10.2164/jandrol.04152. View

16.

Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D . Ultrasound examination of polycystic ovaries: is it worth counting the follicles?. Hum Reprod. 2003; 18(3):598-603. DOI: 10.1093/humrep/deg115. View

17.

Zini A, Bielecki R, Phang D, Zenzes M . Correlations between two markers of sperm DNA integrity, DNA denaturation and DNA fragmentation, in fertile and infertile men. Fertil Steril. 2001; 75(4):674-7. DOI: 10.1016/s0015-0282(00)01796-9. View

18.

Qiao J, Feng H . Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2010; 17(1):17-33. PMC: 3001338. DOI: 10.1093/humupd/dmq032. View

19.

Lopes S, Sun J, Jurisicova A, Meriano J, Casper R . Sperm deoxyribonucleic acid fragmentation is increased in poor-quality semen samples and correlates with failed fertilization in intracytoplasmic sperm injection. Fertil Steril. 1998; 69(3):528-32. DOI: 10.1016/s0015-0282(97)00536-0. View

20.

Sha T, Wang X, Cheng W, Yan Y . A meta-analysis of pregnancy-related outcomes and complications in women with polycystic ovary syndrome undergoing IVF. Reprod Biomed Online. 2019; 39(2):281-293. DOI: 10.1016/j.rbmo.2019.03.203. View